Peer Nørkjær
Direktor/Vorstandsmitglied bei The Danish Association of the Pharmaceutical Industry
Profil
Peer Nørkjær currently works at The Danish Association of the Pharmaceutical Industry, as Director from 2006.
Mr. Nørkjær also formerly worked at Johnson & Johnson, as Chief Executive Officer, Phillips-Medisize A, as Vice Chairman, Pharma Israel, as Chairman, Janssen-Cilag International NV, as Managing Director-Denmark, Ciba-Geigy Denmark, as Marketing Director, The Danish Association of the Pharmaceutical Industry, as Director in 1996, and AstraZeneca, Inc., as Principal.
Mr. Nørkjær received his graduate degree in 1983 from Copenhagen Business School and graduate degree in 1978 from the University of Copenhagen.
Aktive Positionen von Peer Nørkjær
| Unternehmen | Position | Beginn |
|---|---|---|
| The Danish Association of the Pharmaceutical Industry | Direktor/Vorstandsmitglied | 17.05.2010 |
Ehemalige bekannte Positionen von Peer Nørkjær
| Unternehmen | Position | Ende |
|---|---|---|
| The Danish Association of the Pharmaceutical Industry | Direktor/Vorstandsmitglied | 02.01.1996 |
| Ciba-Geigy Denmark | Vertrieb & Marketing | - |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
| Pharma Israel | Vorsitzender | - |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Ausbildung von Peer Nørkjær
| University of Copenhagen | Graduate Degree |
| Copenhagen Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Phillips-Medisize A/S
 Phillips-Medisize A/S Medical SpecialtiesHealth Technology Phillips-Medisize A/S designs, develops, and manufactures injection, inhalation, and connectivity devices. It co-markets intelligent patient compliance device solutions that enable patients to manage their drug treatment regimes. The firm offers pressurized metered dose inhalers, such as Asmair for asthma and chronic obstructive pulmonary diseases; and Insulair, for use with liquid drug formulations for pulmonary drug delivery in patients with diabetes; and tablet reminders. The company's injection technology accelerators are focuses on modules and concept solutions for: disposable and reusable concepts, mechanical and electronic motor systems, dosing controls, needle protection systems, low and high volume concepts, data collection and memory systems, and wireless data transfer systems. Medicom Innovation Partner was founded in 1989 and is headquartered in Struer, Denmark. | Health Technology |
Janssen-Cilag International NV
Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Health Technology |
| Pharma Israel | |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
| Ciba-Geigy Denmark | |
| The Danish Association of the Pharmaceutical Industry |
